Funding for this research was provided by:
National Science Foundation (DGE-1656518, 2019284848)
U.S. Department of Health & Human Services | National Institutes of Health (F99DK126120, 5UM1HG009436-02, 1DP2HD084a06901, R01AI143757, R01AI148623, DP5OD021369, R01GM131073)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35M128947)
Received: 9 November 2021
Accepted: 1 September 2022
First Online: 10 October 2022
: M.G.D., J.T., A.F., M.H., M.C.B., L.B., A.S.B. and P.D.H. are inventors on intellectual property related to this work. P.D.H. is a cofounder of Spotlight Therapeutics and Moment Biosciences and serves on the boards of directors and scientific advisory boards and is a scientific advisory board member to Vial Health, Serotiny and Varda Space. A.S.B. serves on the scientific advisory boards of ArcBio and Caribou Biosciences. M.G.D., A.F., J.T., L.B., M.C.B., A.S.B. and P.D.H. acknowledge outside interest in Stylus Medicine. The remaining authors declare no competing interests.